SC Filed 2019-08-12 Event — SEC 0001193125-19-219124 →

PDL BIOPHARMA, INC. → Evofem Biosciences, Inc. EVFM

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

4,845 shares short · -51.8% vs prior

Other 13D/G Filings on Evofem Biosciences, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-04	SCHEDULE 13D	Hub Cyber Security Ltd.	9.99%	14,709,204	view →
2021-05-20	SC	Invesco Ltd.	—	—	view →
2021-04-27	SC	Invesco Ltd.	—	—	view →
2021-03-31	SC	Invesco Ltd.	—	—	view →
2020-06-09	SC	Invesco Ltd.	—	—	view →
2019-10-11	SC	PDL BIOPHARMA, INC.	—	—	view →
2019-06-12	SC	Invesco Ltd.	—	—	view →
2019-04-15	SC	Invesco Ltd.	—	—	view →
2019-02-12	SC	Invesco Ltd.	—	—	view →

Other Filings by PDL BIOPHARMA, INC.

Filed	Form	Issuer	Stake	Shares
2019-10-11	SC	Evofem Biosciences, Inc. EVFM	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →